The US Lateral Flow Assays Market was valued at $2670.2 Million in 2025 and projected to reach to $3797 Million by 2030, representing a compound annual growth rate of 7.3%. The US lateral flow assays market is positioned for sustained growth through 2030, driven by increasing demand for rapid diagnostic solutions, expanding home-based testing adoption, and chronic disease management needs.
The US lateral flow assays market is valued at $2,670.2 million in 2025, with projected growth to $3,797.0 million by 2030, driven by robust healthcare spending and diagnostic innovation.
The US market demonstrates a 7.3% CAGR through 2030, outpacing global growth rates due to high adoption of point-of-care testing and advanced healthcare infrastructure across clinical and home-use settings.
The FDA's streamlined approval pathways and strong regulatory frameworks accelerate lateral flow technology innovation, enabling rapid commercialization of new diagnostic solutions in the US market.
US healthcare providers increasingly prioritize rapid, decentralized diagnostics, with lateral flow assays becoming standard in emergency departments, clinics, and retail pharmacies nationwide.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SEXUALLY TRANSMITTED INFECTION TESTING (Disease Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 8% from 2025 to 2030 |
| Largest Segment | KITS & REAGENTS (Product) |
| Market Size Base Year (Billions) | ~USD 8.52 (2025) |
| Revenue Forecast (Billions) | ~USD 12.52 (2030) |
| Segments Covered | Product, Application, Type, Disease Type, Technique |
5 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|
The US lateral flow assays market is valued at $2,670.2 million in 2025 and is expected to grow to $3,797.0 million by 2030.
The US lateral flow assays market is projected to grow at a compound annual growth rate (CAGR) of 7.3% from 2025 to 2030.
Growth in the US market is driven by advanced healthcare infrastructure, high adoption of point-of-care diagnostics, favorable reimbursement policies, aging population demographics, and expanding applications in chronic disease management.
In the US, lateral flow assays are widely used for infectious disease testing, pregnancy detection, drug screening, and increasingly for chronic disease management and personalized medicine applications.
By 2030, the US market is expected to see continued expansion driven by technological advancements, product diversification, integration into clinical workflows, and growing adoption of home-use diagnostic solutions.
The study involved major activities in estimating the current market size for the global lateral flow assays market.
Exhaustive secondary research was done to collect information on the lateral flow assays industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the lateral flow assays market.
The four steps involved in estimating the market size are:
The secondary research process involves the widespread use of secondary sources, directories, databases, white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as US Food and Drug Administration, World Health Organization (WHO), Centers for Disease Control and Prevention, International Organization for Standardization (ISO), Agency for Healthcare Research and Quality, were referred to identify and collect information for the global lateral flow assays market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the lateral flow assays market. The primary sources from the demand side include hospitals, clinics, diagnostic laboratories, pharmaceutical and biotechnology companies. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.
The following is a breakdown of the primary respondents:
Note 1: Other designations include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global lateral flow assays market. All the major service providers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. The global lateral flow assays market was split into various segments and sub-segments based on:
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.
The research methodology used to estimate the market size includes the following:

After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Lateral flow assays, or lateral flow immunochromatographic assays, are simple-to-use diagnostic devices to confirm the presence or absence of a target analyte, such as pathogens or biomarkers in humans or animals, or contaminants in water supplies, without requiring specialized equipment.
Full forecast, segment splits, and company analysis for all Lateral Flow Assays Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report